ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+108.1%
5Y CAGR+51.7%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+108.1%/yr
vs -22.4%/yr prior
5Y CAGR
+51.7%/yr
Recent acceleration
Acceleration
+130.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$225.70M+257.6%
2024$63.12M-40.8%
2023$106.60M+325.7%
2022$25.04M+703.6%
2021$3.12M-88.9%
2020$28.13M-53.7%
2019$60.73M-12.1%
2018$69.10M+20.9%
2017$57.16M+1.5%
2016$56.31M-